Inequity in cardiometabolic hospital admissions and blood screening in New Zealand Indigenous Māori with psychosis.

Psychosis blood screening cardiometabolic health health equity indigenous health

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
24 Sep 2024
Historique:
medline: 24 9 2024
pubmed: 24 9 2024
entrez: 24 9 2024
Statut: epublish

Résumé

People with psychosis experience worse cardiometabolic health than the same-aged general population. In New Zealand, Indigenous Māori experiencing psychosis have greater risk of cardiometabolic and other physical health problems. To identify a cohort of adults accessing secondary mental health and addiction services in New Zealand, with a previous psychosis diagnosis as of 1 January 2018, and compare odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening between Māori and non-Māori in the following 2 years. Crude and adjusted logistic regression models compared odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening (lipids and haemoglobin A A cohort ( Māori experiencing psychosis are more likely to die and be admitted to hospital with cardiovascular disease or diabetes than non-Māori. Because of the higher cardiometabolic risk borne by Māori, it is suggested that cardiometabolic screening shortfalls will lead to worsening physical health inequities for Māori experiencing psychosis.

Sections du résumé

BACKGROUND BACKGROUND
People with psychosis experience worse cardiometabolic health than the same-aged general population. In New Zealand, Indigenous Māori experiencing psychosis have greater risk of cardiometabolic and other physical health problems.
AIMS OBJECTIVE
To identify a cohort of adults accessing secondary mental health and addiction services in New Zealand, with a previous psychosis diagnosis as of 1 January 2018, and compare odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening between Māori and non-Māori in the following 2 years.
METHOD METHODS
Crude and adjusted logistic regression models compared odds of hospital admission outcomes, mortality and receipt of cardiometabolic blood screening (lipids and haemoglobin A
RESULTS RESULTS
A cohort (
CONCLUSIONS CONCLUSIONS
Māori experiencing psychosis are more likely to die and be admitted to hospital with cardiovascular disease or diabetes than non-Māori. Because of the higher cardiometabolic risk borne by Māori, it is suggested that cardiometabolic screening shortfalls will lead to worsening physical health inequities for Māori experiencing psychosis.

Identifiants

pubmed: 39314152
doi: 10.1192/bjo.2024.759
pii: S2056472424007592
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e159

Subventions

Organisme : Health Research Council of New Zealand
ID : 21/558

Auteurs

Nathan J Monk (NJ)

Department of Māori/Indigenous Health Innovation, University of Otago, Christchurch, New Zealand.

Ruth Cunningham (R)

Department of Public Health, University of Otago, Wellington, New Zealand.

James Stanley (J)

Department of Public Health, University of Otago, Wellington, New Zealand.

Julie Fitzjohn (J)

Specialist Mental Health Service, Te Whatu Ora/Health New Zealand - Waitaha/Canterbury, New Zealand.

Melissa Kerdemelidis (M)

Population Health Gain, Service Improvement and Innovation, Te Whatu Ora/Health New Zealand - Waitaha/Canterbury, New Zealand.

Helen Lockett (H)

Department of Public Health, University of Otago, Wellington, New Zealand; and Te Pou, Auckland, New Zealand.

Andre D McLachlan (AD)

Centre for Health and Social Practice, Waikato Institute of Technology, Hamilton, New Zealand.

Richard J Porter (RJ)

Specialist Mental Health Service, Te Whatu Ora/Health New Zealand - Waitaha/Canterbury, New Zealand; and Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.

Waikaremoana Waitoki (W)

Faculty of Māori and Indigenous Studies, University of Waikato, Hamilton, New Zealand.

Cameron Lacey (C)

Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.

Classifications MeSH